Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-06

Clinical Trial Update: Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating imiquimod with laser therapy, with or without a green dye, in patients with stage III or stage IV melanoma that has spread to the skin.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod (imiquimod)

Snippet

Sponsor: University of Oklahoma | Conditions: Melanoma (Skin), Metastatic Cancer | Phase 1 | Status: COMPLETED